|
- Myelodysplastic syndromes - Diagnosis and treatment - Mayo Clinic
Treatment Management of myelodysplastic syndromes is most often intended to slow the disease, ease symptoms and prevent complications There's no cure for myelodysplastic syndromes, but some medications can help slow the progression of the disease If you have no symptoms, treatment might not be needed right away
- Treating Myelodysplastic Syndromes | MDS Treatment
Treating Myelodysplastic Syndromes If you’ve been diagnosed with a myelodysplastic syndrome (MDS), your treatment team will discuss your options with you It’s important to weigh the benefits of each treatment option against the possible risks and side effects
- Myelodysplastic Syndromes Treatment - NCI
Myelodysplastic syndromes (MDS) treatment options include supportive care, drug therapy, and chemotherapy with allogeneic stem cell transplant Learn more about newly diagnosed or recurrent MDS and its treatment in this expert-reviewed summary
- Myelodysplastic Syndrome (MDS): Symptoms, Diagnosis Treatment
Myelodysplastic syndrome (MDS) is a group of cancers that affect how blood cells develop MDS is rare Read on to learn about symptoms and treatment
- Myelodysplastic Syndromes (MDS): Causes, Symptoms, Treatment
You might be more likely to get MDS after treatment for acute lymphocytic leukemia in childhood, Hodgkin's disease, or non-Hodgkin's lymphoma
- Treatment for Myelodysplastic Syndrome (MDS) | Memorial Sloan . . .
Doctors at Memorial Sloan Kettering are experts in treating myelodysplastic syndrome (MDS) Learn more about treatment options for MDS
- NCCN Guidelines for Patients: Myelodysplastic Syndromes
There is more than one treatment for lower-risk myelodysplastic syndrome (MDS) This chapter presents all of the treatment options recommended by NCCN MDS experts at this time
- 3 Innovative Myelodysplastic Syndrome Treatment Options | MD . . .
Higher-risk myelodysplastic syndrome patients usually need more aggressive therapy, but much depends on the age and condition of the patient Younger patients with high-risk disease are considered for front-line chemotherapy approaches followed perhaps by allogeneic stem cell transplantation
|
|
|